EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing non-antibiotic anti-infective products (“NovaBay”), today announced that it has entered into a securities purchase agreement for the sale of $6,863,000 of its common stock and warrants to purchase common stock in a private placement.
Help employers find you! Check out all the jobs and post your resume.
